Stocks · Health care · Surgical & Medical Instruments & Apparatus

Pulmonx Corp

LUNG Clue Score49
United States Fiscal year ends December CIK 0001127537 Results filed 27 Oct 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Daniel P Florin
8 Dec 2025
Director
Sold on a plan
23,321
$1.99
$46.41K
Glendon E. French III
20 Mar 2025
Director
Sold on a plan
20,000
$7.85
$157.00K
David Aaron Lehman
3 Mar 2025
General Counsel
Sold on a plan
13,622
$7.97
$108.57K
David Aaron Lehman
3 Mar 2025
General Counsel
Sold on a plan
2,397
$7.14
$17.11K
David Aaron Lehman
3 Mar 2025
General Counsel
Sold on a plan
4,490
$7.14
$32.06K
David Aaron Lehman
3 Mar 2025
General Counsel
Sold on a plan
1,177
$7.14
$8.40K
David Aaron Lehman
3 Mar 2025
General Counsel
Sold on a plan
669
$7.14
$4.78K
Glendon E. French III
20 Feb 2025
Director
Sold on a plan
12,417
$8.76
$108.77K
Glendon E. French III
20 Feb 2025
Director
Sold on a plan
43,036
$8.14
$350.31K
Glendon E. French III
17 Jan 2025
Director
Sold on a plan
2,221
$6.50
$14.44K
Glendon E. French III
16 Jan 2025
Director
Sold on a plan
2,326
$6.53
$15.19K
Glendon E. French III
22 Nov 2024
Director
Sold on a plan
20,000
$6.63
$132.60K
Glendon E. French III
17 Oct 2024
Director
Sold on a plan
20,000
$6.52
$130.40K
Glendon E. French III
12 Sep 2024
Director
Sold on a plan
20,000
$8.09
$161.80K
Geoffrey Beran Rose
24 Jun 2024
Chief Commercial Officer
Sold on a plan
1,184
$6.16
$7.29K
Geoffrey Beran Rose
22 May 2024
Chief Commercial Officer
Sold on a plan
1,184
$8.71
$10.31K
Geoffrey Beran Rose
22 Apr 2024
Chief Commercial Officer
Sold on a plan
1,184
$7.49
$8.87K
Geoffrey Beran Rose
22 Mar 2024
Chief Commercial Officer
Sold on a plan
1,184
$9.36
$11.08K
Geoffrey Beran Rose
22 Feb 2024
Chief Commercial Officer
Sold on a plan
1,184
$14.20
$16.81K
Glendon E. French III
15 Feb 2024
President and CEO
Sold on a plan
20,000
$14.60
$292.00K
Geoffrey Beran Rose
22 Jan 2024
Chief Commercial Officer
Sold on a plan
1,184
$13.13
$15.55K
Glendon E. French III
18 Jan 2024
President and CEO
Sold on a plan
10,000
$12.77
$127.70K
Geoffrey Beran Rose
22 Dec 2023
Chief Commercial Officer
Sold on a plan
1,184
$12.75
$15.10K
Glendon E. French III
21 Dec 2023
President and CEO
Sold on a plan
10,000
$12.42
$124.20K
Geoffrey Beran Rose
22 Nov 2023
Chief Commercial Officer
Sold on a plan
1,184
$10.60
$12.55K
Geoffrey Beran Rose
23 Oct 2023
Chief Commercial Officer
Sold on a plan
1,184
$8.35
$9.89K
Geoffrey Beran Rose
22 Sep 2023
Chief Commercial Officer
Sold on a plan
1,184
$10.51
$12.44K
Geoffrey Beran Rose
23 Aug 2023
Chief Commercial Officer
Sold on a plan
1,184
$10.54
$12.48K
Glendon E. French III
20 Jul 2023
President and CEO
Sold on a plan
15,000
$12.68
$190.20K
Glendon E. French III
15 Jun 2023
President and CEO
Sold on a plan
10,000
$12.68
$126.80K
Showing 250 of 319 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 201
Amendments (4/A) skipped 7
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 30
Sales straight out of an exercise 9
Sales at will 265
Transactions with no price 0
Shares from compensation/vesting 15,282,604
Sales filed before the plan box existed 106
History held since 2 Oct 2020